Moclobemide has 2 known drug interactions based on U.S. FDA drug labeling data. Of these, 2 are contraindicated combinations that should be avoided entirely. Notable interactions include combinations with Rizatriptan Benzoate, Trazodone Hydrochloride. Patients taking Moclobemide should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 2
- Contraindicated
- 2
Contraindicated (2)
- Moclobemide + Rizatriptan Benzoate— MAO-A inhibitor increases rizatriptan AUC by 119% and active metabolite AUC by >400%. Concomitant use is contraindicated…
- Moclobemide + Trazodone Hydrochloride— Concomitant use increases risk of serotonin syndrome. Trazodone is contraindicated in patients taking MAOIs.